Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Nearly half of all states have an adult obesity prevalence of 35% or higher, new CDC data show.
Ozempic and related medications are changing how ordinary people as well as medical experts think about obesity.
New research by Dana-Farber scientists looks at elevated body mass index and chemotherapy for acute lymphoblastic leukemia (ALL).
GLP-1 analog medications improved the functionality of cancer-fighting natural killer cells.
BMI may not be the best way to assess health risks linked to excess weight.
Physical activity was associated with greater gut bacteria diversity and reduced inflammation in people with colon cancer.
Some 20% of those with NAFLD also showed signs of liver fibrosis.
Breast cancer survivor Warrior Megsie muses about how cancer can change your hair—and how fat shaming can make you feel.
The weight-to-height ratio, never meant as a diagnostic tool, is used to determine insurance coverage of weight loss therapies.
Study findings also show that excess body fat and a family history of any cancer may help determine the need for cancer screening.
Alcohol consumption guidelines don’t take into account the greater risk associated with body weight.
Excess body fat, inflammation and insulin resistance are linked to breast cancer in post-menopausal women. Here’s how to lower the risk.
Weight loss, exercise and a healthy diet are keys to managing type 2 diabetes.
People treated with semaglutide for 68 weeks lost an average of 14.9% of their initial body weight.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
Weight-loss surgery especially reduced obesity-related cancers in people with liver cirrhosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.